Health Canada
Canada — Health Canada
Pre-market Requirements for Medical Device Cybersecurity
Authority
Health Canada, Medical Devices Bureau
Enforced
Jun 2019 (rev. 2024)
Legal framework
Medical Devices Regulations (SOR/98-282)
Scope
Class II, III, IV devices with software. Cybersecurity evidence required as part of licence application.
Pre-market
Risk management, secure design, verification evidence in licence application; aligns with FDA SPDF.
Post-market
Mandatory problem reporting, CVD plan, software change reports.
SBOM
RecommendedNot strictly mandatory but strongly aligned to FDA expectations; reuse FDA package.
Vulnerability disclosure
Recommended via Canadian Centre for Cyber Security (CCCS).
Penalty
Licence cancellation, suspension, public advisories.
Unique requirements
- 01Bilingual labelling and IFU
- 02Canadian Importer or Resident
- 03MDSAP audit accepted in lieu of dedicated QMS audit
Highlights
- Aligned with FDA 2023 guidance
- MDSAP-friendly evidence reuse
- Bilingual labelling (EN/FR)
Aligns with
Timeline
-
Jun 2019
Original guidance published
-
2024
Update aligned to FDA 2023 guidance
Key documents
Pre-market Requirements for Medical Device Cybersecurity (Health Canada)
https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/application-information/guidance-documents/cybersecurity.html
Medical Devices Regulations SOR/98-282
https://laws-lois.justice.gc.ca/eng/regulations/sor-98-282/
Health Canada head-to-head
Related markets
Frequently asked about Canada
Is SBOM required for medical devices in Canada?
Recommended. Not strictly mandatory but strongly aligned to FDA expectations; reuse FDA package.
What does Health Canada require for pre-market cybersecurity?
Risk management, secure design, verification evidence in licence application; aligns with FDA SPDF.
What are the post-market cybersecurity obligations under Health Canada?
Mandatory problem reporting, CVD plan, software change reports.
What is the penalty for non-compliance with Health Canada cybersecurity rules?
Licence cancellation, suspension, public advisories.
How much of my FDA cybersecurity package is reusable in Canada?
Roughly 95% — an editorial estimate based on overlapping evidence requirements (threat model, SBOM, security risk assessment, pen-test report).